An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Overview of attention for article published in New England Journal of Medicine, June 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 130 news outlets
blogs: 16 blogs
policy: 2 policy sources
twitter: 554 X users
patent: 36 patents
facebook: 16 Facebook pages

wikipedia: 9 Wikipedia pages
reddit: 9 Redditors
f1000: 1 research highlight platform
guideline: 6 clinical guideline sources
bluesky: 1 Bluesky user

Readers on

mendeley: 1040 Mendeley

So far, Altmetric has seen 17 posts from 16 blogs.

Special Edition: What's Next—An Update on Beta Cell Function

Diabetes Core Update, 10 Nov 2025

In this special episode on a Beta Cell Update Dr. Neil Skolnik discusses this emerging area with Dr. Melena Bellin. This…

First UK Patients Receive Diabetes Drug That Delays Symptoms by Years

Science Alert, 09 Jul 2025

Groundbreaking.

Special Edition - Early Identification and Delay of Type 1 Diabetes April 2025

Diabetes Core Update, 14 Apr 2025

In this special episode on Early Identification and Delay of Type 1 Diabetes, Dr. Neil Skolnik this emerging area with Dr. Jay…

Strategies for earlier detection of type 1 diabetes in children

Common Sense Family Doctor, 24 Aug 2024

An estimated 1.8 million people in the United States, or nearly 1 in 250 children and 1 in 200 adults, have type 1 diabetes. One…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 13 additional blog posts.